Oue Y, Kanatani H, Kiyoki M, Eto Y, Ogata E, Matsumoto T
Teijin Institute for Biomedical Research, Teijin Ltd., Tokyo, Japan.
Bone. 1994 May-Jun;15(3):361-6. doi: 10.1016/8756-3282(94)90301-8.
In order to examine the effect of activin A on the process of bone formation, activin A was injected onto the periosteum of parietal bone in newborn rats, and the effect was compared with that of transforming growth factor (TGF)-beta. The daily periosteal injection of activin A increased the thickness of both the periosteal and bone matrix layers in a dose- and time-dependent manner. A maximal effect was obtained with 5.0 micrograms/day activin A. The time course of the effect of activin A on the periosteal thickness was similar to that of TGF-beta 1. However, the effect of TGF-beta 1 was much more pronounced and was mainly on fibroblasts and inflammatory cells. The time course of the effect of activin A on the thickness of bone matrix layer was different from that of TGF-beta 1. The effect of TGF-beta 1 reached maximum (1.8-fold) within 3 days, whereas that of activin A did not develop until day 6 and reached maximum at the end of the 12-day injection period (1.4-fold). Histological examinations revealed that both TGF-beta 1 and activin A increased the number of alkaline phosphatase-positive osteoblastic cells. These results demonstrate that periosteal injection of activin A stimulates bone formation. In addition, although the possibility cannot be ruled out that the dramatic effect of TGF-beta 1 on the periosteal layer might have affected the delivery of TGF-beta 1 to the bone surface, these observations also suggest that the mode of action of activin A may be different from that of TGF-beta 1.(ABSTRACT TRUNCATED AT 250 WORDS)
为了研究激活素A对骨形成过程的影响,将激活素A注射到新生大鼠顶骨的骨膜上,并与转化生长因子(TGF)-β的作用进行比较。每日骨膜注射激活素A可使骨膜层和骨基质层的厚度以剂量和时间依赖性方式增加。每天注射5.0微克激活素A可获得最大效果。激活素A对骨膜厚度的作用时间进程与TGF-β1相似。然而,TGF-β1的作用更为明显,主要作用于成纤维细胞和炎性细胞。激活素A对骨基质层厚度的作用时间进程与TGF-β1不同。TGF-β1的作用在3天内达到最大值(1.8倍),而激活素A的作用直到第6天才出现,并在12天注射期结束时达到最大值(1.4倍)。组织学检查显示,TGF-β1和激活素A均增加了碱性磷酸酶阳性成骨细胞的数量。这些结果表明,骨膜注射激活素A可刺激骨形成。此外,尽管不能排除TGF-β1对骨膜层的显著作用可能影响了TGF-β1向骨表面的递送,但这些观察结果也表明激活素A的作用方式可能与TGF-β1不同。(摘要截短至250字)